Research progress on diagnostic methods of multidrug-resistant tuberculosis

doi:10.3969/j.issn.1000-6621.2021.03.017

Abstract

Abstract:

The prevention and control of multidrug-resistant tuberculosis (MDR-TB) is of great significance for tuberculosis (TB) prevention and control, and has become a difficult and hot issue in the TB prevention and control field. Early detection of MDR-TB by conducting drug susceptible test can improve the treatment success rate of MDR-TB patients. The diagnostic methods of MDR-TB include traditional culture methods and new molecular biological diagnostic methods. The author did a literature review to the diagnostic methods of MDR-TB and hope it could provide more scientific evidences for MDR-TB prevention and treatment.

Key words: Mycobacterium tuberculosis, Tuberculosis,multidrug-resistant, Diagnosis, Molecular diagnostic techniques

ZHANG Chun-xia, XU Gui-sheng, SHI Jin-yan. Research progress on diagnostic methods of multidrug-resistant tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 291-294. doi: 10.3969/j.issn.1000-6621.2021.03.017

References 37

[1]	杨松, 严晓峰. 贝达喹啉治疗耐多药与广泛耐药结核病的现状和展望. 结核病与肺部健康杂志, 2019,8(4):249-252. doi: 10.3969/j.issn.2095-3755.2019.04.004.
[2]	World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
[3]	刘一典, 桂徐蔚, 申晓娜, 等. 2019年《ATS/CDC/ERS/IDSA临床实践指南:耐药结核病治疗》解读及与我国《耐药结核病化学治疗指南(2019年)》对比. 中国防痨杂志, 2020,42(1):12-16. doi: 10.3969/j.issn.1000-6621.2020.01.005.
[4]	Bolhuis MS, van der Werf TS, Akkerman OW. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med, 2020,382(24):2376-2377. doi: 10.1056/NEJMc2009939. doi: 10.1056/NEJMc2009939 URL pmid: 32521141
[5]	中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019,41(10):1025-1073. doi: 10.3969/j.issn.1000-6621.2019.10.001.
[6]	朱庆义. 结核分枝杆菌耐多药基因及其检测新技术. 中华临床实验室管理电子杂志, 2020,8(2):65-70. doi: 10.3877/cma.j.issn.2095-5820.2020.02.001.
[7]	Lange C, Chesov D, Heyckendorf J, et al. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Respirology, 2018,23(7):656-673. doi: 10.1111/resp.13304. doi: 10.1111/resp.13304 URL pmid: 29641838
[8]	Schön T, Miotto P, Köser CU, et al. Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives. Clin Microbiol Infect, 2017,23(3):154-160. doi: 10.1016/j.cmi.2016.10.022. doi: 10.1016/j.cmi.2016.10.022 URL pmid: 27810467
[9]	World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization, 2009.
[10]	Rancoita PMV, Cugnata F, Gibertoni Cruz AL, et al. Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2018,62(9):e00344-18. doi: 10.1128/AAC.00344-18. doi: 10.1128/AAC.00344-18 URL pmid: 29941636
[11]	李辉. 液体培养方法在结核病和耐药结核病诊断中的应用. 中华检验医学杂志, 2014,37(8):637-638. doi: 10.3760/cma.j.issn.1009-9158.2014.08.019.
[12]	Sivaramakrishnan G, Subramanyam B, Kumar MP, et al. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis. Int J Mycobacteriol, 2019,8(4):329-332. doi: 10.4103/ijmy.ijmy_151_19. doi: 10.4103/ijmy.ijmy_151_19 URL pmid: 31793501
[13]	Opota O, Mazza-Stalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect, 2019,25(11):1370-1376. doi: 10.1016/j.cmi.2019.03.021. doi: 10.1016/j.cmi.2019.03.021 URL pmid: 30928564
[14]	World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization, 2008.
[15]	World Health Organization. The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. Geneva: World Health Organization, 2016.
[16]	World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis—rapid diagnostics for tuberculosis detection. Geneva: World Health Organization, 2020.
[17]	Lee JH, Jo KW, Shim TS. Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance. Tuberc Respir Dis (Seoul), 2019,82(2):143-150. doi: 10.4046/trd.2018.0027.
[18]	Siddiqui S, Brooks MB, Malik AA, et al. Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan. PLoS One, 2019,14(8):e0221485. doi: 10.1371/journal.pone.0221485. doi: 10.1371/journal.pone.0221485 URL pmid: 31425565
[19]	Rufai SB, Umay K, Singh PK, et al. Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective. PLoS One, 2020,15(3):e0229419. doi: 10.1371/journal.pone.0229419. URL pmid: 32130233
[20]	Yasemin A, Ahmad S, Afzal S, et al. Evaluation of GeneXpert MTB/RIF Assay for Detection of Pulmonary Tuberculosis on Sputum Samples. J Coll Physicians Surg Pak, 2019,29(1):66-69. doi: 10.29271/jcpsp.2019.01.66. doi: 10.29271/jcpsp.2019.01.66 URL pmid: 30630573
[21]	Shao L, Qiu C, Zheng L, et al. Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: A multicentre prospective study. Int J Infect Dis, 2020,98:441-446. doi: 10.1016/j.ijid.2020.06.076. URL pmid: 32599283
[22]	Ali IF, Babak F, Fazlollah MS, et al. Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical Specimens. Asian Pac J Trop Biomed, 2014,4(Suppl 1):S165-170. doi: 10.12980/APJTB.4.2014C1186. doi: 10.12980/APJTB.4.2014C1186 URL pmid: 25183075
[23]	Choi W, Lee J, Cho E, et al. Accurate and effective multidrug-resistant Mycobacterium tuberculosis detection method using gap-filling ligation coupled with high-resolution capillary electrophoresis-based single strand conformation polymorphism. Sci Rep, 2017,7:46090. doi: 10.1038/srep46090. doi: 10.1038/srep46090 URL pmid: 28422112
[24]	Tahmasebi P, Farnia P, Sheikholslami F, et al. Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP. Iran J Microbiol, 2012,4(4):165-170. URL pmid: 23205246
[25]	李栋梁, 侯瑞生, 王侃, 等. PCR-SSCP法检测结核分枝杆菌耐药基因突变分析. 中国卫生检验杂志, 2014,24(21):3127-3128.
[26]	Coll F, McNerney R, Preston MD, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med, 2015,7(1):51. doi: 10.1186/s13073-015-0164-0. doi: 10.1186/s13073-015-0164-0 URL pmid: 26019726
[27]	Doyle RM, Burgess C, Williams R, et al. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. J Clin Microbiol, 2018,56(8):e00666-18. doi: 10.1128/JCM.00666-18.
[28]	Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998,393(6685):537-544. doi: 10.1038/31159. doi: 10.1038/31159 URL pmid: 9634230
[29]	Roa MB, Tablizo FA, Morado EKD, et al. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines. J Glob Antimicrob Resist, 2018,15:239-245. doi: 10.1016/j.jgar.2018.08.009. doi: 10.1016/j.jgar.2018.08.009 URL pmid: 30130640
[30]	Gröschel MI, Walker TM, van der Werf TS, et al. Pathogen-based precision medicine for drug-resistant tuberculosis. PLoS Pathog, 2018,14(10):e1007297. doi: 10.1371/journal.ppat.1007297. doi: 10.1371/journal.ppat.1007297 URL pmid: 30335850
[31]	Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis, 2018,18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. doi: 10.1016/S1473-3099(18)30496-1 URL pmid: 30342828
[32]	Tagliani E, Hassan MO, Waberi Y, et al. Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey. Sci Rep, 2017,7(1):17672. doi: 10.1038/s41598-017-17705-3. doi: 10.1038/s41598-017-17705-3 URL pmid: 29247181
[33]	Colman RE, Mace A, Seifert M, et al. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. PLoS Med, 2019,16(4):e1002794. doi: 10.1371/journal.pmed.1002794. doi: 10.1371/journal.pmed.1002794 URL pmid: 31039166
[34]	Tyler AD, Christianson S, Knox NC, et al. Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis. PLoS One, 2016,11(2):e0148676. doi: 10.1371/journal.pone.0148676. doi: 10.1371/journal.pone.0148676 URL pmid: 26849565
[35]	Daniyarov A, Molkenov A, Rakhimova S, et al. Whole genome sequence data of Mycobacterium tuberculosis XDR strain, isolated from patient in Kazakhstan. Data Brief, 2020,33:106416. doi: 10.1016/j.dib.2020.106416. doi: 10.1016/j.dib.2020.106416 URL pmid: 33102665
[36]	Rosse IC, Assis JG, Oliveira FS, et al. Whole genome sequencing of Guzerá cattle reveals genetic variants in candidate genes for production, disease resistance, and heat tolerance. Mamm Genome, 2017,28(1/2):66-80. doi: 10.1007/s00335-016-9670-7.
[37]	Ko DH, Lee EJ, Lee SK, et al. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. Ann Clin Microbiol Antimicrob, 2019,18(1):2. doi: 10.1186/s12941-018-0300-y. doi: 10.1186/s12941-018-0300-y URL pmid: 30606210